Pyruvate (CSF)
Use
CSF Pyruvate is useful for investigating possible disorders of mitochondrial, metabolism, when used in conjunction with cerebrospinal fluid lactate collected at the same time to determine the Lactate:Pyruvate ratio. The CSF Lactate:Pyruvate ratio is considered a helpful (not diagnostic) tool in the evaluation of patients with possible disorders of mitochondrial metabolism, especially in patients with neurologic dysfunctin and normal blood Lactate:Pyruvate ratios. Pyruvic acid levels alone have little clinical utility. The Lactate:Pyruvate raio is elevated in several, but not all, mitochondrial respiratory chain disorders. Mitochondrial disorders vary widely in presentation and age of onset. Many mitochondrial disorders have neurologic and myopathic features and may involve multiple organ systems. Determination of lactate, pyruvate, and L:P ratio in cerebrospinal fluid is helpful in directing attention toward a possible mitochondrial disorder in cases with predominatly neurologic dysfunction and normal blood lactate levels. An elevated Lactate:Pyruvate ratio may indicate inherited disorders of the respiratory chain complex, tricarboxylic acid cycle disorders and pyruvate carboxylase deficiency. Respiratory chain defects usually result in Lactate:Pyruvate ratios >20. A low Lactate: Pyruvate ratio (disproportionately elevated pyruvic acid) may indicate an inherited disorder of pyruvate metabolism. Defects of the pyruvate dehydrogenase complex result in Lactate:Pyruvate ratios <10. The Lactate:Pyruvate ratio is characteristically normal in other patients. An artifactually high ratio can be found in acutely ill patients.
Special Instructions
The Lactate:Pyruvate ratio is elevated in some mitochondrial respiratory chain disorders. Many mitochondrial disorders have neurological and myopathic features. It is important to analyze lactate, pyruvate, and their ratio to direct focus towards potential mitochondrial disorders in cases with predominant neurological dysfunction and normal blood lactate levels.
Limitations
This test was developed and its performance characteristics were determined by LabCorp. It has not been cleared or approved by the Food and Drug Administration. The results are subject to variation. An artifactual increase in Lactate:Pyruvate ratio may occur in acutely ill patients. The Lactate:Pyruvate ratio can vary and provide different indicators, such as low ratios indicating a defect in pyruvate metabolism and high ratios indicating disorders of respiratory chain complex.
Methodology
Other
Biomarkers
Result Turnaround Time
10-14 days
Related Documents
For more information, please review the documents below
Specimen
Cerebrospinal Fluid
Volume
1.0 mL
Minimum Volume
0.5 mL
Container
Sterile screw capped vial
Collection Instructions
Collect the entire sample into a single sterile tube. Immediately after collection, add a 2:1 ratio (acid:sample) of cold 8% perchloric acid. Vortex for 30 seconds, and place on ice for 5 minutes. Store frozen at -20°C and ship frozen.
Storage Instructions
Freeze as soon as possible after collection.
Causes for Rejection
Bloody CSF; received thawed; sample received untreated
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | Unstable |
| Refrigerated | 24 hours |
| Frozen | -20°C = 72 hours; -80°C = Indefinite |
